5 SIMPLE TECHNIQUES FOR AGO TUMOR

Hormonal therapy stays the treatment of to start with choice for metastatic patients with endocrine-responsive breast most cancers (LoE 1a A, AGO ++). The sequential use with the obtainable medications will depend on the individual pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at enough time of prognosis of relapse is recommended W